Results 171 to 180 of about 13,154 (208)

Association of statin use with pathological complete response in postmenopausal patients with hormone receptor-positive breast cancer. [PDF]

Sci Rep
Ersoy M.
europepmc   +1 more source

A novel approach to assessing the bioavailability of biopeptide inhibitor of HMG CoA reductase from germinated and ungerminated Kara Kratok (<i>Phaseolus lunatus</i> L.). [PDF]

PeerJ
Budiyanto C, Ningrum A, Murdiati A, Indrati R.   +3 more
europepmc   +1 more source

Pitavastatin Reduces Major Atherosclerotic Cardiovascular Events in Adults with HIV. [PDF]

J Am Board Fam Med
Garner KK, Colvin C, Cardon B.
europepmc   +1 more source

Advancing Lipid Management in Europe: Insights from the WHF Regional Roundtable Series and Country Case Studies. [PDF]

Glob Heart
Raspail L, Taylor S, Van Lennep JR, González-Juanatey JR, Ray KK, Santos RD.   +5 more
europepmc   +1 more source

Statins as Antifungal Agents: A Review on Drug Repurposing and Nanotechnology-Driven Delivery Strategies. [PDF]

Fundam Clin Pharmacol
E Silva DM, de Souza Lacerda L, de Souza Andrioli A, Braz WR, Campos LM, de Paiva MRB, Pittella F, Fabri RL, Tavares GD.   +8 more
europepmc   +1 more source

Lipid, lipid-lowering drugs, and bleedings: A Mendelian randomization and retrospective study. [PDF]

Sci Prog
Guo S, Hu S, Chen H, Chen KY.
europepmc   +1 more source

Mévalonate dans la cellule végétale (Le) [PDF]

Holef, Caroline
core  

Reduction of Brain β-Amyloid（Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments （APP-CTFs) and Aβ Clearance

Reduction of Brain β-Amyloid（Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments （APP-CTFs) and Aβ Clearance
openaire  

Some of the next articles are maybe not open access.

Related searches:

The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors

Letters in Drug Design & Discovery, 2019
High cholesterol and triglyceride levels are mainly related to further generation of lifethreating metabolism disorders including cardiovascular system diseases. Therefore, hypercholesterolemia (i.e., also referred to as hyperlipoproteinemia) is a serious disease state, which must be controlled.
ERDOĞAN ORHAN, İLKAY, Gulcan, Hayrettin Ozan, Yigitkan, Serkan   +2 more
openaire   +4 more sources

Effect of Hydroxymethylglutaryl-CoA Reductase Inhibitors on the Functional Properties of Erythrocyte Membranes

Experimental and Molecular Pathology, 1993
We studied 56 patients affected by primary hypercholesterolemia treated with placebo for 1 month and with simvastatin (20 mg/day) or pravastatin (20 mg/day) for 6 months during a double-blind clinical trial. At 1-month intervals we determined the following parameters in the serum: total and HDL cholesterol, triglycerides, and apolipoprotein A-1 and B ...
R A, Rabini, M, Polenta, R, Staffolani, M, Tocchini, R, Signore, I, Testa, L, Mazzanti   +6 more
openaire   +2 more sources